BioCryst Pharmaceuticals
BCRX
#4910
Rank
A$2.81 B
Marketcap
A$10.96
Share price
0.27%
Change (1 day)
2.60%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2026 (TTM): A-$1.89

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$2.02. In 2025 the company made an earnings per share (EPS) of A$1.87 an increase over its 2024 EPS that were of A-$0.64.

EPS history for BioCryst Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.89-201.29%
2025A$1.87-390.7%
2024A-$0.64-63.56%
2023A-$1.77-11.28%
2022A-$1.9929.13%
2021A-$1.54-4.63%
2020A-$1.6210.2%
2019A-$1.470%
2018A-$1.4725.64%
2017A-$1.174%
2016A-$1.1227.12%
2015A-$0.88-13.24%
2014A-$1.0223.64%
2013A-$0.82-30.38%
2012A-$1.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
A-$4.64 129.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.31-313.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A-$3.94 94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A-$0.30-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A-$2.27 12.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.51 222.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A-$0.66-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$4.76 135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$7.54 273.33%๐Ÿ‡บ๐Ÿ‡ธ USA